Journal
JACC-CARDIOVASCULAR IMAGING
Volume 14, Issue 4, Pages 758-778Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jcmg.2020.12.015
Keywords
edge-to-edge repair; outcome; right ventricular function; right ventricular-to-pulmonary artery coupling; secondary mitral regurgitation; tricuspid regurgitation
Funding
- Abbott
- Amgen
- Bristol Myers Squibb
- Bayer
- Boston Scientific
- Biotronik
- CSL
- Medtronic
- Edwards Lifesciences
- Sinomed
- Polares
- Abbot Vascular
- Abbott Vascular
Ask authors/readers for more resources
The study assessed the impact of right ventricular dysfunction on survival after TMVR for severe SMR and found that it was a major predictor of adverse outcomes. The findings emphasize the importance of assessing right ventricular function when planning TMVR for SMR patients.
OBJECTIVES This study sought to assess the impact of right ventricular dysfunction (RVD) as defined by impaired right ventricular-to-pulmonary artery (RV-PA) coupling, on survival after edge-to-edge transcatheter mitral valve repair (TMVR) for severe secondary mitral regurgitation (SMR). BACKGROUND Conflicting data exist regarding the benefit of TMVR in severe SMR. A possible explanation could be differences in RVD. METHODS Using data from the EuroSMR (European Registry on Outcomes in Secondary Mitral Regurgitation) registry, this study compared the characteristics and outcomes of SMR patients undergoing TMVR, according to their RV-PA coupling, assessed by tricuspid annular plane systolic excursion-to-systolic pulmonary artery pressure (TAPSE/sPAP) ratio. RESULTS Overall, 817 patients with severe SMR and available RV-PA coupling assessment underwent TMVR in the participating centers. RVD was present in 211 patients (25.8% with a TAPSE/sPAP ratio <0.274 mm/mm Hg). Although all patients demonstrated significant improvement in their New York Heart Association (NYHA) functional class, there was a trend toward a lower rate of NYHA functional class I or II among patients with RVD (56.5% vs. 65.5%, respectively; p = 0.086) after TMVR. Survival rates at 1 and 2 years were lower among patients with RVD (70.2% vs. 84.0%, respectively; p < 0.001; and 53.4% vs. 73.1%, respectively; p < 0.001). On multivariate analysis, a reduced TAPSE/sPAP ratio was a strong predictor of mortality (odds ratio: 1.62; 95% confidence interval: 1.14 to 2.31; p = 0.007). CONCLUSIONS RVD, as shown by impairment of RV-PA coupling, is a major predictor of adverse outcome in patients undergoing TMVR for severe SMR. The often neglected functional and anatomic RV parameters should be systematically assessed when planning TMVR procedures for patients with severe SMR. (C) 2021 Published by Elsevier on behalf of the American College of Cardiology Foundation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available